(ABOS) Acumen Pharmaceuticals - Performance -46.6% in 12m
ABOS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-81.52%
#144 in Peer-Group
Rel. Strength
10.36%
#6869 in Stock-Universe
Total Return 12m
-46.56%
#121 in Peer-Group
Total Return 5y
-93.03%
#135 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 3.54 USD |
| 52 Week Low | 0.90 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 93.66 |
| Buy/Sell Signal +-5 | 1.67 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ABOS (-46.6%) vs XBI (-11.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.02% | 61.8% | 74.7% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.89% | -8.76% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.19% | -6.24% | 38% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-2.29% | 26.9% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.48% | -8.9% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
11.5% | 27.6% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.47% | 46.2% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.64% | 26.9% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ABOS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ABOS
| Total Return (including Dividends) | ABOS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 22.81% | 3.15% | 4.01% |
| 3 Months | 26.13% | 17.08% | 17.14% |
| 12 Months | -46.56% | -11.14% | 13.46% |
| 5 Years | -93.03% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | ABOS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 38.1% | 52.1% | 90.3% |
| 3 Months | 68.5% | 79.4% | 97.5% |
| 12 Months | -91.7% | -87.4% | 46.4% |
| 5 Years | -86% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th88.50 | 19.06% | 18.07% |
| 3 Month | %th60.00 | 7.72% | 7.67% |
| 12 Month | %th39.50 | -39.87% | -52.91% |
| 5 Years | %th37.50 | -88.93% | -95.46% |
FAQs
Does Acumen Pharmaceuticals (ABOS) outperform the market?
No,
over the last 12 months ABOS made -46.56%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%.
Over the last 3 months ABOS made 26.13%, while XBI made 17.08%.
Performance Comparison ABOS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ABOS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 20.2% | 18.8% | -19.9% | -60% |
| US NASDAQ 100 | QQQ | 20.3% | 18.6% | -21.9% | -60% |
| German DAX 40 | DAX | 19.9% | 21.6% | -32% | -77% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 19% | 18.3% | -24.3% | -65% |
| Hongkong Hang Seng | HSI | 19.3% | 20% | -41.9% | -82% |
| India NIFTY 50 | INDA | 21.6% | 23.6% | -20.3% | -44% |
| Brasil Bovespa | EWZ | 24.4% | 23.4% | -34.9% | -48% |
ABOS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 21.6% | 21.1% | -23.2% | -70% |
| Consumer Discretionary | XLY | 19.3% | 19.5% | -12.2% | -65% |
| Consumer Staples | XLP | 22.3% | 23% | -18.9% | -54% |
| Energy | XLE | 17.3% | 18.7% | -12.3% | -49% |
| Financial | XLF | 21.7% | 20.2% | -22.2% | -72% |
| Health Care | XLV | 20.1% | 22.8% | -8.4% | -40% |
| Industrial | XLI | 19.8% | 18.4% | -25.7% | -70% |
| Materials | XLB | 19.6% | 18.3% | -20.5% | -51% |
| Real Estate | XLRE | 20.5% | 22.9% | -18.3% | -55% |
| Technology | XLK | 20.3% | 16.2% | -25% | -58% |
| Utilities | XLU | 20.2% | 20.2% | -23.9% | -67% |
| Aerospace & Defense | XAR | 19.6% | 16% | -39.8% | -96% |
| Biotech | XBI | 16.6% | 19.7% | -9.6% | -35% |
| Homebuilder | XHB | 17.2% | 14.1% | -13.3% | -45% |
| Retail | XRT | 20.3% | 19.6% | -15% | -53% |
ABOS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 19.6% | 19.5% | -5.94% | -42% |
| Natural Gas | UNG | 22% | 29.3% | 6.2% | -45% |
| Gold | GLD | 20.1% | 22.6% | -37.8% | -85% |
| Silver | SLV | 15.9% | 16.5% | -41.9% | -69% |
| Copper | CPER | 9.9% | 7.9% | -39.4% | -70% |
ABOS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 21.1% | 22.8% | -14.5% | -42% |
| iShares High Yield Corp. Bond | HYG | 20.8% | 21.7% | -16.9% | -56% |